Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Mar;270(3):1211-1214.
doi: 10.1007/s00415-022-11487-z. Epub 2022 Nov 18.

Persistent hiccups as main COVID-19 manifestation with transient cytotoxic lesion of the corpus callosum splenium during the Omicron wave in the post-vaccination era

Affiliations

Persistent hiccups as main COVID-19 manifestation with transient cytotoxic lesion of the corpus callosum splenium during the Omicron wave in the post-vaccination era

Celeste Sassi et al. J Neurol. 2023 Mar.
No abstract available

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no conflict of interest.

Figures

Fig. 1
Fig. 1
A-S Neuroradiological features detected in the patient described. A–K CT-Angiography of thorax, head and neck, 5 days post COVID-19 Omicron infection. A Axial-CT-Scan displaying an old left thalamic infarct (blue arrow). B-C Thorax-CT axial and coronal scans, without suggestive features for a COVID-19 Omicron pneumonia. D-K CT-Angiography of head and neck without vessel stenosis or occlusion and nor neuroradiological hallmarks typical for a vasculitis (blue arrows). D Circle of Willis (blue arrow). E Left extracranial carotid artery (blue arrow). F right extracranial carotid artery (blue arrow). G Arteria basilaris (blue arrow). H Left arteria vertebralis (blue arrow). I Right arteria vertebralis (blue arrow). J Anterior pericallosal artery (blue arrow). K Posterior pericallosal artery (blue arrow). L–O axial MRI scans performed 7 days post COVID-19 Omicron infection displaying a round midline lesion in the splenium of the corpus callosum with subtle hyperintensity on fluid attenuated inversion recovery (FLAIR) (L) corresponding to a T2-weighted imaging with restricted diffusion (of ca. 5 x 12 mm) (M) and low signal intensity on apparent diffusion coefficient (ADC) (N) and a very mild hypointense signal on T1-weighted imaging (O) (blue arrows). PS, axial control MRI scans performed 24 days post COVID-19 Omicron infection presenting a complete resolution of the lesion in the splenium of the corpus callosum in the T2-FLAIR sequences (P) as well as in the T2- Diffusion-weighted imaging (DWI) (Q), on apparent diffusion coefficient (ADC) sequences (R) and on T1-weigted imaging (S) (blue arrows), patient asymptomatic and SARS-CoV-2 Rapid Antigen Test negative

References

    1. Taquet M, Sillett R, Zhu L, Mendel J, Camplisson I, Dercon Q, Harrison PJ. Neurological and psychiatric risk trajectories after SARS-CoV-2 infection: an analysis of 2-year retrospective cohort studies including 1 284 437 patients. Lancet Psychiatry. 2022;9:815–827. doi: 10.1016/S2215-0366(22)00260-7. - DOI - PMC - PubMed
    1. Ito N, Kitahara Y, Miwata K, Okimoto M, Takafuta T. Comparison of COVID-19 pneumonia during the SARS-CoV-2 Omicron wave and the previous non-Omicron wave in a single facility. Respir Investig. 2022; : S2212–5345(22)00112–5. - PMC - PubMed
    1. Tetsuka S. Reversible lesion in the splenium of the corpus callosum. Brain Behav. 2019;9:e01440. doi: 10.1002/brb3.1440. - DOI - PMC - PubMed
    1. Takashita E, Yamayoshi S, Simon V, van Bakel H, Sordillo EM, Pekosz A, Fukushi S, Suzuki T, Maeda K, Halfmann P, Sakai-Tagawa Y, Ito M, Watanabe S, et al. Efficacy of antibodies and antiviral drugs against omicron BA.2.12.1, BA.4, and BA.5 Subvariants. N Engl J Med. 2022; 387: 468–70. - PMC - PubMed
    1. Tada H, Takanashi J, Barkovich AJ, Oba H, Maeda M, Tsukahara H, Suzuki M, Yamamoto T, Shimono T, Ichiyama T, Taoka T, Sohma O, Yoshikawa H, et al. Clinically mild encephalitis/encephalopathy with a reversible splenial lesion. Neurology. 2004;63:1854–1858. doi: 10.1212/01.WNL.0000144274.12174.CB. - DOI - PubMed

Publication types

Substances